President Donald Trump plans to announce a “major” tariff on pharmaceutical imports soon, Reuters reports. Trump said the tariff will incentivize drug companies to move their operations into the country. Publicly traded companies in the pharma space include AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- Trump Plans “Major Tariff on Pharmaceuticals” as Global Economies Crumble
- AstraZeneca’s Oncology Breakthroughs: Buy Rating Backed by Promising Pipeline and Strategic Innovations
- Five Best Stocks to Buy in Today’s Fearful Market, According to Analysts
- PM, WM, AZN: 3 Inflation Beating Stocks in the New World of Trump Tariffs
- AstraZeneca’s Imfinzi combination with chemo approved in EU to treat NSCLC